Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation.
Huang W, O'Keefe RJ, Schwarz EM.
Arthritis Res Ther. 2003;5(1):R49-59. Epub 2002 Nov 12.
Similar articles
IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
Khapli SM, Mangashetti LS, Yogesha SD, Wani MR.
J Immunol. 2003 Jul 1;171(1):142-51.
Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.
Kwak HB, Lee SW, Jin HM, Ha H, Lee SH, Takeshita S, Tanaka S, Kim HM, Kim HH, Lee ZH.
Blood. 2005 Apr 1;105(7):2963-9. Epub 2004 Dec 7.
Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis.
Fox SW, Chambers TJ.
Biochem Biophys Res Commun. 2000 Oct 5;276(3):868-72.
RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.
Pang M, Martinez AF, Jacobs J, Balkan W, Troen BR.
Biochem Biophys Res Commun. 2005 Mar 18;328(3):756-63.
Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H.
J Immunol. 2003 Nov 15;171(10):5130-9.
MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival.
Okamatsu Y, Kim D, Battaglino R, Sasaki H, Späte U, Stashenko P.
J Immunol. 2004 Aug 1;173(3):2084-90.
T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.
Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R.
J Bone Miner Res. 2001 Feb;16(2):328-37.
Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis.
De Klerck B, Carpentier I, Lories RJ, Habraken Y, Piette J, Carmeliet G, Beyaert R, Billiau A, Matthys P.
Arthritis Res Ther. 2004;6(3):R220-31. Epub 2004 Mar 12.
Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.
Huber DM, Bendixen AC, Pathrose P, Srivastava S, Dienger KM, Shevde NK, Pike JW.
Endocrinology. 2001 Sep;142(9):3800-8.
Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M, Sato T, Takai H, Watanabe K, Ikeda K, Yamada Y.
J Bone Miner Res. 2000 Jul;15(7):1321-9.
TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype.
Fox SW, Fuller K, Bayley KE, Lean JM, Chambers TJ.
J Immunol. 2000 Nov 1;165(9):4957-63.
Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.
Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T.
J Biol Chem. 2003 Jun 27;278(26):23971-7. Epub 2003 Apr 15.
Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y.
J Biol Chem. 2001 Jan 5;276(1):563-8.
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T.
Nature. 2000 Nov 30;408(6812):600-5.
Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
J Bone Miner Res. 2001 Nov;16(11):2074-81.
Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
Shinoda K, Sugiyama E, Taki H, Harada S, Mino T, Maruyama M, Kobayashi M.
Bone. 2003 Oct;33(4):711-20.
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N.
Endocrinology. 2001 Aug;142(8):3656-62.
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.
Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL.
J Clin Invest. 2000 Dec;106(12):1481-8.
Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia.
Servet-Delprat C, Arnaud S, Jurdic P, Nataf S, Grasset MF, Soulas C, Domenget C, Destaing O, Rivollier A, Perret M, Dumontel C, Hanau D, Gilmore GL, Belin MF, Rabourdin-Combe C, Mouchiroud G.
BMC Immunol. 2002 Oct 24;3:15.
Filters: Manage Filters